Craig-Hallum Downgrades Iteris to Hold, Lowers Price Target to $4.5
Craig-Hallum analyst Ryan Sigdahl downgrades Iteris (NASDAQ:ITI) from Buy to Hold and lowers the price target from $6 to $4.5.
Iteris: Q3 Earnings Insights
Iteris (NASDAQ:ITI) reported its Q3 earnings results on Thursday, February 3, 2022 at 04:05 PM.
Here's what investors need to know about the announcement.
Iteris Q3 GAAP EPS $(0.06), Sales $32.00M Miss $32.64M Estimate
Iteris (NASDAQ:ITI) reported quarterly losses of $(0.06) per share which missed the analyst consensus estimate of $0.01 by 700 percent. The company reported quarterly sales of $32.00 million which missed the analyst
Earnings Scheduled For February 3, 2022
Companies Reporting Before The Bell
• Tuesday Morning (NASDAQ:TUEM) is likely to report earnings for its second quarter.
Iteris Wins $6.8M Subcontract By Parsons Corporation To Deliver Vehicle-To-Infrastructure Connected Bus Signal Priority System For Los Angeles County Metropolitan Transportation Authority
Iteris, Inc. (NASDAQ:ITI), the global leader in smart mobility infrastructure management, today announced that it has been awarded a $6.8 million subcontract by Parsons Corporation (NYSE:PSN) to provide design,
Iteris Selected To Support Development Of Connected Vehicle Data Exchange Platform For Florida Department Of Transportation
Initiative Demonstrates Iteris' Continuous Role as Trusted Advisor to FDOT and Public Transportation Agencies Nationwide
Statewide program will enable FDOT to communicate critical travel information to the
59 Biggest Movers From Yesterday
Gainers
SeaChange International, Inc. (NASDAQ: SEAC) jumped 128.8% to $1.72 following Bloomberg report suggesting that social video app Triller is in merger talks with Seachange.
40 Stocks Moving In Monday’s Mid-Day Session
Gainers
Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) shares climbed 83.4% to $91.52. Pfizer agreed to acquire Arena Pharmaceuticals for $100 per share in an all-cash transaction.